The New England Journal of Medicine has corrected three highly cited papers to credit researchers who played a role in the work. The papers describe a treatment in which engineered T cells fight leukemia, originally hailed as a “major advance” in the New York Times. Since the first paper appeared in 2011, co-author Carl June at the University of Pennsylvania has received more … Continue reading NEJM corrects 3 papers after prominent cancer scientist left off credit for breakthrough